Caijie Lu - Publications

Identification of colon adenocarcinoma necroptosis subtypes and tumor antigens for the development of mRNA vaccines.

Journal: Heliyon

Published: June 03, 2024

Prognostic value of autophagy-related genes based on single-cell RNA-sequencing in colorectal cancer.

Journal: Frontiers in genetics

Published: November 28, 2022

Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer.

Journal: BMC gastroenterology

Published: February 24, 2022

Troglitazone inhibits hepatic oval cell proliferation by inducing cell cycle arrest through Hippo/YAP pathway regulation.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: April 24, 2021

Expression of Wnt3a in hepatocellular carcinoma and its effects on cell cycle and metastasis.

Journal: International journal of oncology

Published: June 20, 2017

Diosmetin Induces Cell Apoptosis by Regulating CYP1A1/CYP1A2 Due to p53 Activation in HepG2 Cells.

Journal: Protein and peptide letters

Published: November 09, 2016

Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells.

Journal: PloS one

Published: September 03, 2014

Notch3 functions as a regulator of cell self-renewal by interacting with the β-catenin pathway in hepatocellular carcinoma.

Journal: Oncotarget

Published: August 07, 2014

Mir-152 inhibits cell proliferation and colony formation of CD133(+) liver cancer stem cells by targeting KIT.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 15, 2014

Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activation-dependent mechanism.

Journal: Scientific reports

Published: November 05, 2013